Manjunath Ramarao

Aragen has appointed Manjunath Ramarao as Chief Scientific Officer

Aragen has announced the appointment of Manjunath Ramarao as Chief Scientific Officer (CSO) and Executive Vice President of Integrated Drug Discovery.

Ramarao has more than 25 years of experience in global biopharmaceutical research and development (R&D) and joins Aragen from Atomic AI, where he served as CSO.

He was also previously CSO at Ribometrix and held multiple leadership positions at Bristol Myers Squibb, culminating in his role as Executive Director, Site Leader for Research and Early Development, and Head of Discovery Biology and Translational Medicine as part of the Biocon-Bristol Myers Squibb R&D Centre.

Ramarao said: “I am delighted to take on my new role at Aragen… I look forward to working closely with the Board, the management team and business leaders in leading the company into a new phase of growth.”

Alongside Ramarao’s appointment, Aragen has named Jayadeva Sajankila as Vice President and Head of Chemical Development Solutions.

Sajankila holds over 26 years of industry experience in process R&D, process safety, technology transfer and commercialisation, and most recently served as Head of Project and Portfolio Management, Chemical Development at Syngene International.

Sajankila said: “I am excited to step into my new role at Aragen. My focus will be on driving innovation, operational excellence and business growth while building a strong, collaborative team.”